More than an Amide Bioisostere: Discovery of 1,2,4-Triazole-containing Pyrazolo[1,5-a]pyrimidine Host CSNK2 Inhibitors for Combatting β-Coronavirus Replication
Authors:
- Han Wee OngHOHan Wee Ong
- Xuan YangXYXuan Yang
- Jeffery SmithJSJeffery Smith
- Rebekah DickmanderRDRebekah Dickmander
- Jason BrownJBJason Brown
- Tammy HavenerTHTammy Havener
- Sharon Taft-BenzSTSharon Taft-Benz
- Stefanie HowellSHStefanie Howell
- Marcia SandersMSMarcia Sanders
- Jacob CapenerJCJacob Capener
- Rafael CouñagoRCRafael Couñago
- Edcon ChangECEdcon Chang
Preprint
- 24 April 2024
- preprint
- Published by American Chemical Society (ACS) in ChemRxiv
Abstract
The pyrazolo[1,5-a]pyrimidine scaffold is a promising scaffold to develop potent and selective CSNK2 inhibitors with antiviral activity against β-coronaviruses. Herein, we describe the discovery of a 1,2,4-triazole group to substitute a key amide group for CSNK2 binding present in many potent pyrazolo[1,5-a]pyrimidine inhibitors. Crystallographic evidence demonstrates that the 1,2,4-triazole replaces the amide in forming key hydrogen bonds with Lys68 and a water molecule buried in the ATP-binding pocket. This isosteric replacement improves potency and metabolic stability at a cost of solubility. Optimization for potency, solubility and metabolic stability led to the discovery of the potent and selective CSNK2 inhibitor 53. Despite excellent in vitro metabolic stability, rapid decline in plasma concentration of 53 in vivo was observed and may be attributed to lung accumulation, although in vivo pharmacological effect was not observed. Further optimization of this novel chemotype may validate CSNK2 as an antiviral target in vivo.Keywords
All Related Versions
Funding Information
- National Institutes of Health (1U24DK116204-01)
This publication has 36 references indexed in Scilit:
- Host directed therapies: COVID-19 and beyondCurrent Research in Pharmacology and Drug Discovery, 2021
- Anti–SARS‐CoV‐2 Repurposing Drug Database: Clinical Pharmacology ConsiderationsCPT: Pharmacometrics & Systems Pharmacology, 2021
- Development of a potent and selective chemical probe for the pleiotropic kinase CK2Cell Chemical Biology, 2021
- Optimization of pyrazolo[1,5-a]pyrimidines lead to the identification of a highly selective casein kinase 2 inhibitorEuropean Journal of Medicinal Chemistry, 2020
- A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory MiceCell, 2020
- The Global Phosphorylation Landscape of SARS-CoV-2 InfectionCell, 2020
- Medicinal chemistry strategies toward host targeting antiviral agentsMedicinal Research Reviews, 2020
- Coral: Clear and Customizable Visualization of Human Kinome DataCell Systems, 2018
- Mitoxantrone, More than Just Another Topoisomerase II PoisonMedicinal Research Reviews, 2015
- Phosphorylation events during viral infections provide potential therapeutic targetsReviews in Medical Virology, 2011